Irinotecan

A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy
Seiji Mabuchi, Eriko Yokoi, Kotaro Shimura, Naoko Komura, Yuri Matsumoto, Kenjiro Sawada, Aki Isobe, Tateki Tsutsui, Fuminori Kitada, Tadashi Kimura

International Journal of Gynecologic Cancer Mar 2019, 29 (3) 474-479; DOI: 10.1136/ijgc-2018-000070
Phase I Clinical Study of Irinotecan Plus S-1 in Patients With Advanced or Recurrent Cervical Cancer Previously Treated With Platinum-Based Chemotherapy
Seiji Mabuchi, Eriko Yokoi, Takao Owa, Katsumi Kozasa, Michiko Yamashita, Eiji Kobayashi, Takuji Tomimatsu, Takeshi Yoki, Tateki Tsutui, Tadashi Kimura

International Journal of Gynecologic Cancer Sep 2016, 26 (7) 1281-1287; DOI: 10.1097/IGC.0000000000000769
Clinical Features of Neuroendocrine Carcinoma of the Uterine Cervix: A Single-Institution Retrospective Review
Shoji Nagao, Maiko Miwa, Naoko Maeda, Ai Kogiku, Kasumi Yamamoto, Akemi Morimoto, Senn Wakahashi, Kotaro Ichida, Tamotsu Sudo, Satoshi Yamaguchi, Toshiko Sakuma, Kiyoshi Fujiwara

International Journal of Gynecologic Cancer Sep 2015, 25 (7) 1300-1305; DOI: 10.1097/IGC.0000000000000495
Combination Treatment With Trabectedin and Irinotecan or Topotecan Has Synergistic Effects Against Ovarian Clear Cell Carcinoma Cells
Mahiru Kawano, Seiji Mabuchi, Toshiko Kishimoto, Takeshi Hisamatsu, Yuri Matsumoto, Tomoyuki Sasano, Ryoko Takahashi, Kenjiro Sawada, Kazuhiro Takahashi, Toshifumi Takahashi, Toshimitsu Hamasaki, Tadashi Kimura

International Journal of Gynecologic Cancer Jun 2014, 24 (5) 829-837; DOI: 10.1097/IGC.0000000000000143
A Modified Shortened Administration Schedule for Neoadjuvant Chemotherapy With Irinotecan and Cisplatin in Locally Advanced Cervical Cancer
Yufeng Ren, Yanfang Li, Jihong Liu

International Journal of Gynecologic Cancer Apr 2011, 21 (4) 685-689; DOI: 10.1097/IGC.0b013e3182129b61
Phase II Clinical Study of the Combination Chemotherapy Regimen of Irinotecan Plus Oral Etoposide for the Treatment of Recurrent Ovarian Cancer (Tohoku Gynecologic Cancer Unit 101 Group Study)
Tadahiro Shoji, Eriko Takatori, Hideo Omi, Seisuke Kumagai, Akira Yoshizaki, Yoshihito Yokoyama, Hideki Mizunuma, Toshio Fujimoto, Tadao Takano, Nobuo Yaegashi, Toru Tase, Kenji Nakahara, Hirohisa Kurachi, Hiroshi Nishiyama, Toru Sugiyama

International Journal of Gynecologic Cancer Jan 2011, 21 (1) 44-50; DOI: 10.1097/IGC.0b013e3181ffbe9f
Phase II study of irinotecan plus doxorubicin for early recurrent or platinum-refractory ovarian cancer: interim analysis
S. Nishimura, H. Tsuda, Y. Hashiguchi, K. Kokawa, R. Nishimura, O. Ishiko, S. Kamiura, K. Hasegawa, N. Umesaki

International Journal of Gynecologic Cancer Jan 2007, 17 (1) 159-163; DOI: 10.1111/j.1525-1438.2006.00728.x

Log in using your username and password

Main menu

Log in using your username and password

You are here

Irinotecan